Gel form of a medication for Parkinson’s disease speeds response time over traditional pills.
Scott Plutchak's diagnosis of transverse myelitis exposed him to a quality of medical communication not often encountered.
Researchers try to answer why to improve targets for further declines in strokes.
Studies zero in on potential biomarkers in muscle tissue for Lou Gehrig’s disease.
A UAB study discovers a pathway used by malignant tumor cells to invade healthy parts of the brain, giving researchers a fresh target for drug discovery.
A grant will establish the new Bachmann-Strauss Dystonia and Parkinson’s Disease Centers of Excellence at UAB and two other medical centers.
Can smell tests reveal brain changes that are precursors to Parkinson's? Research podcast with David Standaert, M.D., Ph.D.
Bebin is co-director of the UAB Tuberous Sclerosis Clinic and a founding member of the TSC Clinical Research Consortium.
UAB Neurology study adds to evidence that massive, second-wave reaction kills nerve cells.